Abstract:BACKGROUND:Pathway alterations reflected as changes in gene expression regulation and gene interaction can result from cellular exposure to toxicants. Such information is often used to elucidate toxicological modes of action. From a risk assessment perspective, alterations in biological pathways are a rich resource for setting toxicant thresholds, which may be more sensitive and mechanism-informed than traditional toxicity endpoints. Here we developed a novel differential networks (DNs) approach to connect pathway perturbation with toxicity threshold setting.METHODS:Our DNs approach consists of 6 steps: time-series gene expression data collection, identification of altered genes, gene interaction network reconstruction, differential edge inference, mapping of genes with differential edges to pathways, and establishment of causal relationships between chemical concentration and perturbed pathways. A one-sample Gaussian process model and a linear regression model were used to identify genes that exhibited significant profile changes across an entire time course and between treatments, respectively. Interaction networks of differentially expressed (DE) genes were reconstructed for different treatments using a state space model and then compared to infer differential edges/interactions. DE genes possessing differential edges were mapped to biological pathways in databases such as KEGG pathways.RESULTS:Using the DNs approach, we analyzed a time-series Escherichia coli live cell gene expression dataset consisting of 4 treatments (control, 10, 100, 1000 mg/L naphthenic acids, NAs) and 18 time points. Through comparison of reconstructed networks and construction of differential networks, 80 genes were identified as DE genes with a significant number of differential edges, and 22 KEGG pathways were altered in a concentration-dependent manner. Some of these pathways were perturbed to a degree as high as 70% even at the lowest exposure concentration, implying a high sensitivity of our DNs approach.CONCLUSIONS:Findings from this proof-of-concept study suggest that our approach has a great potential in providing a novel and sensitive tool for threshold setting in chemical risk assessment. In future work, we plan to analyze more time-series datasets with a full spectrum of concentrations and sufficient replications per treatment. The pathway alteration-derived thresholds will also be compared with those derived from apical endpoints such as cell growth rate.

A Toxicity Pathway-Based Approach for Modeling the Mode of Action Framework of Lead-Induced Neurotoxicity.

Empirical analysis of lead neurotoxicity mode of action and its application in health risk assessment

A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study

Integration of Computational Toxicology, Toxicogenomics Data Mining, and Omics Techniques to Unveil Toxicity Pathways

Neurotoxicity of fine and ultrafine particulate matter: A comprehensive review using a toxicity pathway-oriented adverse outcome pathway framework

Exploring the potential mechanism of atrazine-induced dopaminergic neurotoxicity based on integration strategy

Differential Reconstructed Gene Interaction Networks for Deriving Toxicity Threshold in Chemical Risk Assessment.

Profile of N6-methyladenosine of Pb-exposed neurons presents epitranscriptomic alterations in PI3K-AKT pathway-associated genes

Potential adverse outcome pathways with hazard identification of organophosphate esters

Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro

Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity

A Network Toxicology Approach for Mechanistic Modelling of Nanomaterial Hazard and Adverse Outcomes

Pathway-based Assessment of Single Chemicals and Mixtures by a High-Throughput Transcriptomics Approach

Proof of concept for quantitative adverse outcome pathway modeling of chronic toxicity in repeated exposure

Predicting the Metal Mixture Toxicity with a Toxicokinetic-Toxicodynamic Model Considering the Time-Dependent Adverse Outcome Pathways

Proteome Signatures of Joint Toxicity to Arsenic (as) and Lead (pb) in Human Brain Organoids with Optic Vesicles

Toxicokinetic and Toxicodynamic (TK-TD) Modeling to Study Oxidative Stress-Dependent Toxicity of Heavy Metals in Zebrafish.

Single-cell investigation of lead toxicity from neurodevelopment to neurodegeneration: Current review and future opportunities

Application of Adverse Outcome Pathways Framework in Monitoring of Toxic Chemicals from Aquatic Environments

Prediction of the Neurotoxic Potential of Chemicals Based on Modelling of Molecular Initiating Events Upstream of the Adverse Outcome Pathways of (Developmental) Neurotoxicity

Model of neural development by differentiating human induced pluripotent stem cells into neural progenitor cells to study the neurodevelopmental toxicity of lead